• WVE-210201 Receives FDA Orphan Drug, Rare Pediatric Disease Designations for DMD
  • Seeing Both Sides of the Plastic Straw Controversy
  • Jiffy Lube, MDA Join Forces for 7th Annual MUSCLE UP! Campaign
  • 2 Nonprofits Join Forces to Help Duchenne Patients Fight Insurance Denials
  • First Patient Enrolled in Phase 2 Trial of MNK-1411, Mallinckrodt’s Investigational Therapy for DMD
  • Arizona Woman with Duchenne is a Rarity Among the Rare
  • How Lyrica Has Affected My Relationship with Food
  • $700,000 MDA Grant to Help Establish LGMD Clinical Research Network
  • New Online Resource, DuchenneXchange, and Its Offerings Explained in Aug. 7 Webinar
  • Family’s Quest for ‘Overlooked’ Duchenne Treatments Leads to Breast Cancer Medicine Tamoxifen
  • FDA Places Hold on Phase 1/2 Trial of Sarepta’s Gene Therapy for DMD
  • Consortium.AI to Advance New Treatments for Duchenne Using Artificial Intelligence